Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa
jniittymaa0 / Pixabay

Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

People with epidermolysis bullosa (EB) often experience symptoms such as intense itching or severe pain. Unfortunately, these symptoms can be debilitating and may greatly affect overall quality-of-life. However, some burgeoning…

Continue Reading Study Shares Calcipotriol Benefits for Dystrophic Epidermolysis Bullosa

Studies of Head and Neck Cancer Show That Black Patients Have Worse Overall Survival Than Other People of Color

Researchers are aware that Black cancer patients experience worse outcomes than white cancer patients due to the differences in access to health care. According to a report in Cancer Network,…

Continue Reading Studies of Head and Neck Cancer Show That Black Patients Have Worse Overall Survival Than Other People of Color
Hypoparathyroidism Reduces Quality-of-Life, Study Shares
Parkinson's disease and dystonia are difficult diseases to live with for many reasons, not the least of which is that often drug therapy doesn't provide enough relief.

Hypoparathyroidism Reduces Quality-of-Life, Study Shares

It is no secret that certain conditions can sometimes be debilitating or make it harder to partake in day-to-day life. According to Hypoparathyroidism News, researchers recently sought to understand the…

Continue Reading Hypoparathyroidism Reduces Quality-of-Life, Study Shares
Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival
source: pixabay.com

Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival

From January 20th through the 22nd, 2022, researchers, specialists, and other stakeholders descended on the Gastrointestinal Cancers Symposium to discuss new and innovative research on gastrointestinal cancers. During the Symposium,…

Continue Reading Adding Docetaxel to Cisplatin, 5-FU Improves Esophageal Cancer Overall Survival
SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup
source: pixabay.com

SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup

Targeted Oncology recently featured a discussion by Dr. Jennifer Brown, director of Dana Farber’s Chronic Lymphocytic Leukemia Center, on the interim results from the SEQUOIA Phase 3 trial. The trial…

Continue Reading SEQUOIA Trial Results Show Remarkable Response Rate in High-Risk CLL Subgroup
Researchers Identify Underlying Mechanism and Possible Treatment of Usher Syndrome
source: pixabay.com

Researchers Identify Underlying Mechanism and Possible Treatment of Usher Syndrome

Vision loss is a symptom associated with a number of disorders, one of which is Usher syndrome. Medical professionals have spent years trying to fully comprehend the underlying mechanisms of…

Continue Reading Researchers Identify Underlying Mechanism and Possible Treatment of Usher Syndrome